Journal Information
Vol. 45. Issue 4.
Pages 516-518 (October - December 2023)
Share
Share
Download PDF
More article options
Vol. 45. Issue 4.
Pages 516-518 (October - December 2023)
Letter to the Editor
Full text access
Fluorescence in situ hybridization (FISH) in imprint of biopsies suspected of lymphoproliferative neoplasms: report on 17 cases
Visits
1626
Roberta Maria da Silva Oliveira Safranauskas
Corresponding author
roberta_oliveirasp@yahoo.com.br

Corresponding author at: Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701 – Morumbi, 05652-900 São Paulo, SP, Brazil.
, Denise da Cunha Pasqualin, Renata Kiyomi Kishimoto, Maria Marta Silva, Cristina Kaori Oki, Renee Zon Filippi, Alanna Mara Pinheiro Sobreira Bezerra, Elvira Deolinda Rodrigues Pereira Velloso
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Additional material (1)
Full Text
Dear Editor,

The diagnosis of lymphoproliferative neoplasms is mainly established by morphological and immunophenotypic aspects of Formalin-Fixed Paraffin Embedded (FFPE) tissue.1 However, distinct genetic alterations have been specifically associated with some lymphoproliferative neoplasms, and its identification may be crucial for a complete diagnosis.2,3 Fluorescence In Situ Hybridization (FISH) technique can be applied to different types of sample preparation, such as methanol–acetic acid fixed cells suspensions, tissue imprints and FFPE.4,5 The FISH technique in dewaxed tissue sections is widely used and very challenging, depending on pre-analytical processes such as fixation and paraffinization; cell overlap is also an obstacle.6,7 Due to these difficulties, we propose to validate the FISH technique in imprint of biopsies from several materials suspected of having lymphoproliferative neoplasms.

Imprint slides from 17 tissue samples: lymph nodes (n = 12), muscle lesion, mediastinal mass, chest wall lesion, thyroid and lung (n = 1, each) with suspected lymphomas (n = 15) or myeloid sarcoma (n = 2) were performed by pathologists during excisional or core biopsy. Four to 5 imprint slides were prepared for each fragment, dried at room temperature and sent to the cytogenetic laboratory. One slide per case was stained with Rosenfeld dye and the others were stored at room temperature; FISH technique was performed within 90 days. The same probes already used for routine laboratory FISH in cell suspension were validated for this type of sample. Break apart IGH probe was performed in all cases and CMYC, BCL2 and BCL6 (break apart probes: Cytocell®, Cambridge, UK) were also used in two samples. Interphase FISH analysis was performed under a fluorescence microscope by two analysts with a total score of 100 nuclei, reference values previously established in bone marrow cell suspensions; IGH, CMYC, BCL2, BCL6 rearrangements cut-offs were 8.5%, 11.9%, 4.6% and 6.0%, respectively.5,8

Hybridization was successful in all samples. Four of the six samples diagnosed with non- Hodgkin B cell lymphoma (NHL-B) presented IGH rearrangement, two also presented with CMYC and BCL2 rearrangements (Diffuse B cell lymphoma double hit) (Figure 1). In one case of T cell NHL and one case of undifferentiated neoplasia, a gain in the IGH signal was observed. Two cases of Hodgkin Lymphoma, two thymomas, three reactive lymphoid proliferations and two myeloid sarcomas showed normal FISH IGH study (supplementary Table 1).

Figure 1.

Diffuse large B-cell lymphoma, double hit (lymph nodes biopsy). (A) Imprint slide stained with Rosenfeld. (B) Lymph node shows neoplastic lymphoid cell (Rosenfeld, ×500). (C) Interphase FISH analyses using probes dual fusion break apart showing IGH, CMYC and BCL2 rearrangements (one normal fusion signal and one red and one green signals) and three copies of BCL6 gene (three fusion signals).

(0.29MB).

FISH in FFPE material is a useful technique, but dependent on pre-analytical factors and is limited by the smaller variety of commercial probes. This study validated the FISH technique in imprint of various tissues, showing to be easy to perform, score and interpret, being a quick and useful option for diagnostic purposes.

References
[1]
S.H. Swerdlow, E. Campo, N.L. Harris, et al.
WHO classification of tumours of haematopoietic and lymphoid tissues.
4th ed., International Agency for Research on Cancer, (2008),
[2]
K.J. Savage, N.A. Johnson, S. Ben-Neriah, J.M. Connors, L.H. Sehn, P. Farinha, et al.
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.
Blood, 114 (2009), pp. 3533-3537
[3]
M.G. Tibiletti.
Specificity of interphase fluorescence in situ hybridization for detection of chromosome aberrations in tumor pathology.
Cancer Genet Cytogenet, 155 (2004), pp. 143-148
[4]
M.G. Tibiletti, B. Bernasconi, A. Dionigi, C. Riva.
The applications of FISH in tumor pathology.
Adv Clin Pathol, 3 (1999), pp. 111-118
[5]
C.H. Garcia, R.M.D.S.O. Safranauskas, A.M.P.S. Bezerra, E.D.R.P. Velloso.
Cytogenetic studies for cMYC, BCL2 and BCL6 genes in neoplasm: comparison of karyotype, FISH in paraffin-embedded tissue and FISH in methanol-acetic acid-fixed cells suspensions.
Hematol Transfus Cell Ther, 43 (2021), pp. 521-526
[6]
E. Hyytinen, T. Visakorpi, A. Kallioniemi, O.P. Kallioniemi, J.J. Isola.
Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Cytometry, 16 (1994), pp. 93-99
[7]
E. Haralambieva, A.H. Banham, C. Bastard, G. Delsol, P. Gaulard, G. Ott, S. Pileri, J.A. Fletcher, D.Y. Mason.
Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples.
Br J Haematol, 121 (2003), pp. 49-56
[8]
R.S. Tanizawa, C.A. Kumeda, R.S. de Azevedo Neto, A.M Leal, P.B Ferreira, E.D Velloso.
Karyotypic and fluorescent in situ hybridization study of the centromere of chromosome 7 in secondary myeloid neoplasms.
Rev Bras Hematol Hemoter, 33 (2011), pp. 425-431
Copyright © 2023. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools
Supplemental materials